Our vision is a world where cancer patients are diagnosed early and treated precisely to achieve cure.
To achieve this vision, we have formed a multidisciplinary team of molecular biologists, clinicians, technologists, and computational biologists that fosters cross-pollination of ideas. We leverage this diverse range of expertise to develop cutting edge diagnostic tools based on liquid biopsies. In the process, we train the next generation of translational scientists developing the skills and knowledge required to address pressing clinical needs in precision cancer medicine, in the US and globally.
Recent Posts
Murtaza Lab wins 2024 WARF Innovation Award
December 15, 2024Murtaza Lab nominated for WARF 2024 Innovation Award
November 19, 2024Comings and Goings
November 4, 2024- More News